Abstract:The "sphingosin" backbone of sphingolipids was so named by J. L. W. Thudichum in 1884 for its enigmatic ("Sphinx-like") properties. Although still an elusive class of lipids, research on the involvement of sphingolipids in the signal transduction pathways that mediate cell growth, differentiation, multiple cell functions, and cell death has been rapidly expanding our understanding of these compounds. In addition to the newly discovered role of ceramide as an intracellular second messenger for tumor necrosis factor-alpha, IL-1beta, and other cytokines, sphingosine, sphingosine-1-phosphate, and other sphingolipid metabolites have recently been demonstrated to modulate cellular calcium homeostasis and cell proliferation. Perturbation of sphingolipid metabolism using synthetic and naturally occurring inhibitors of key enzymes of the biosynthetic pathways is aiding the characterization of these processes; for examples, inhibition of cerebroside synthase has indicated a role for ceramide in cellular stress responses including heat shock, and inhibition of ceramide synthase (by fumonisins) has revealed the role of disruption of sphingolipid metabolism in several animal diseases. Fumonisins are currently the focus of a FDA long-term tumor study. This review summarizes recent research on (i) the role of sphingolipids as important components of the diet, (ii) the role of sphingoid base metabolites and the ceramide cycle in expression of genes regulating cell growth, differentiation, and apoptosis, (iii) the use of cerebroside synthase inhibitors as tools for understanding the role of sphingolipids as mediators of cell cycle progression, renal disease, and stress responses, and (iv) the involvement of disrupted sphingolipid metabolism in animal disease and cellular deregulation associated with exposure to inhibitors of ceramide synthase and serine palmitoyltransferase, key enzymes in de novo sphingolipid biosynthesis. These findings illustrate how an understanding of the function of sphingolipids can help solve questions in toxicology and this is undoubtedly only the beginning of this story.

Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid

Post-translational regulation of sphingosine kinases

Sphingolipids and their metabolism in physiology and disease

Principles of bioactive lipid signalling: lessons from sphingolipids

Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.

Sphingolipid-Induced Bone Regulation and Its Emerging Role in Dysfunction Due to Disease and Infection

Bioactive sphingolipids as emerging targets for signal transduction in cancer development

Perspective: Therapeutic Implications for Sphingolipids in Health and Disease

Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology

Sphingosine 1-phosphate: Lipid signaling in pathology and therapy

Regulation of cellular and systemic sphingolipid homeostasis

Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy

Drug Development in the Field of Sphinogolipid Metabolism

Mysterious sphingolipids: metabolic interrelationships at the center of pathophysiology

Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming

Sphingosine Kinase-1 Enhances Endothelial Cell Survival Through a PECAM-1–dependent Activation of PI-3K/Akt and Regulation of Bcl-2 Family Members

Modulation of protein kinase C and diverse cell functions by sphingosine--a pharmacologically interesting compound linking sphingolipids and signal transduction

The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance

Critical Roles of the Sphingolipid Metabolic Pathway in Liver Regeneration, Hepatocellular Carcinoma Progression and Therapy

Human Sphingosine Kinase: Purification, Molecular Cloning and Characterization of the Native and Recombinant Enzymes

Sphingolipid metabolism and signaling in cardiovascular diseases